BDBM484728 US10934297, Compound 141::US11713320, Compound 141

SMILES CN1CCC(n2cc(NC(=O)c3n[nH]c4ccc(-c5cnn(C)c5)cc34)cn2)CC1

InChI Key InChIKey=DQWBYCBUTPEWFQ-UHFFFAOYSA-N

Data  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 484728   

LigandChemical structure of BindingDB Monomer ID 484728BDBM484728(US10934297, Compound 141 | US11713320, Compound 14...)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at estrogen receptor beta (unknown origin) assessed as inhibition of estradiol-induced response after 22 hrs by cell-based lucife...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2026
Entry Details PubMed
LigandChemical structure of BindingDB Monomer ID 484728BDBM484728(US10934297, Compound 141 | US11713320, Compound 14...)
Affinity DataEC50:  1nMAssay Description:Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2023
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 484728BDBM484728(US10934297, Compound 141 | US11713320, Compound 14...)
Affinity DataEC50:  1nMAssay Description:DYRK1A: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2021
Entry Details
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 484728BDBM484728(US10934297, Compound 141 | US11713320, Compound 14...)
Affinity DataEC50:  4nMAssay Description:Each compound is dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2023
Entry Details
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Biosplice Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 484728BDBM484728(US10934297, Compound 141 | US11713320, Compound 14...)
Affinity DataEC50:  4nMAssay Description:GSK3β: Each compound is dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-respo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2021
Entry Details
US Patent